查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1840849

眼科缝合线市场：按产品类型、材料、缝合线类型、应用、最终用户和缝合线尺寸 - 全球预测 2025-2032

Ophthalmic Sutures Market by Product Type, Material, Suture Type, Application, End User, Suture Size - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年眼科缝合线市场将成长至 7.8093 亿美元，复合年增长率为 7.86%。

主要市场统计数据
基准年2024年 4.2607亿美元
预计2025年 4.5902亿美元
预测年份：2032年 7.8093亿美元
复合年增长率（%） 7.86%

简要介绍临床重点、技术差异和购买驱动因素，为每种手术场景的现代眼科缝合线选择提供信息

眼科缝合线仍然是前后段手术的基本组成部分，其材料科学、操作特性和监管途径的细微差别决定了临床选择。过去十年，外科医生和采购团队越来越重视减少组织反应、可预测的线结安全性以及在显微镜下操作的便利性等指标。这些因素推动了可吸收和不可吸收缝合线的多样化发展，并促使供应商改进聚合物配方和线材结构，以满足显微外科手术的需求。

专用缝线尺寸和样式在临床实践中越来越多地用于支撑脆弱的眼部组织。从10-0到9-0的超细规格缝线可实现精准的角膜和水晶体修復，而更大规格的缝线则可满足更广泛的重组需求。同时，缝线类型（编织线与单丝线）的差异会影响组织阻力、线结形状和感染风险，进而影响外科医师根据手术情况所做的选择。同时，终端使用者环境（例如门诊手术中心、专科眼科诊所和医院眼科部门）正在透过病例组合、吞吐量需求和无菌处理能力来影响采购标准。

总的来说，这些动态为产品培训、供应可靠性以及符合外科医生程序和设施要求的有针对性的材料创新的策略投资奠定了基础。

为什么聚合物创新、不断发展的显微外科技术和采购整合从根本上改变了眼科缝合线的临床使用和供应商策略

近年来，眼科缝合线领域发生了一些变革，这些变革正在重新调整製造商、临床医生和供应链相关人员的处理方式。聚合物化学和长丝工程的进步改进了氧环己酮聚合体和Polyglactin910等可吸收产品，同时提高了聚酰胺和聚酯等不可吸收纤维的表面光洁度和拉伸可靠性。这些材料层面的创新降低了组织阻力，并提高了缝线的安全性，这直接转化为术中效率和术后癒合轨迹。

同时，不断发展的临床技术和对微创方法的重视，推动了对能够无创伤地穿过脆弱眼组织的超细缝合线和单丝的需求。训练和外科医生的偏好趋势强调了操作特性的重要性。因此，製造商正在投资触觉测试和外科医生主导的可用性研究，以使其产品线更具差异化。另一个显着的变化是采购管道的整合，以及门诊手术中心、眼科诊所和医院各科室对即时库存的推动。

这种转变将要求相关人员在技术创新与严格的临床检验和可靠的物流之间取得平衡，为能够展示材料性能和供应弹性的公司创造机会。

评估 2025 年美国关税调整对眼科缝合用品筹资策略、供应链弹性和合约条款的影响

2025年美国的政策转变和关税调整将为包括眼科缝线在内的外科耗材的采购筹资策略带来新的变数。某些医疗设备类别的进口课税上调，促使医疗保健买家和经销商重新评估其供应商布局，并探索能够降低海关和前置作业时间风险的近岸外包和区域采购模式。这促使一些製造商加快对本地生产的投资，或签署双重采购协议，以维持医院、门诊手术中心和眼科诊所的连续性。

这些变化也影响着商业合约的结构。买家越来越倾向于签订包含与贸易政策变化相关的价格变动条款的长期合同，并坚持要求提高原产国标籤和关税转嫁的透明度。对于产品开发团队而言，监管和海关的复杂性提升了统一的品质系统和备案合规证据的价值，这些证据可在必要时支持替代采购。因此，任何供应链或材料采购的变更都必须透过台架试验和临床等效性方案进行检验，才能大规模采用。

总体而言，2025 年的关税环境正在加速供应链多样化，凸显采购透明度的重要性，并重塑供应商和最终用户之间的谈判，以确保临床上重要的眼科缝合产品的稳定供应。

将聚合物化学、长丝结构、外科应用和最终用户购买行为与产品策略联繫起来的详细细分见解

了解产品和应用细分，可以揭示临床需求与供应商能力最密切相关的交集。将产品依产品类型分为可吸收和不可吸收两类，可以发现，当临床重点关注组织吸收和减少异物长期存在时，聚氧环己酮聚合体、Polyglactin910和Polyglycolic等可吸收材料通常是首选；而当临床需要持久拉伸支撑时，聚酰胺、聚酯和丝绸等不可吸收纤维则是首选。依材料分类，聚酰胺、聚对二氧氧环己酮聚合体、聚酯、Polyglactin910、Polyglycolic和丝绸等聚合物的选择，其操作特性和生物相容性各不相同，可以指南外科医生的选择和标籤要求。

将缝合线类型细分为编织线和单丝线，可以突出线结安全性和组织阻力之间的权衡，这对于用于眼前节手术的超细缝合线（例如10-0、9-0、8-0、7-0和6-0）尤其重要。应用细分涵盖白内障、角膜、青光眼和水晶体修復，可以明确临床手术需求并帮助确定产品组合的优先顺序。例如，白内障和角膜手术通常需要最细的线径和最低的组织阻力，而青光眼手术可能更注重长期拉伸稳定性。对最终用户（例如门诊手术中心、眼科诊所和医院）进行细分，可以突出采购週期、库存量和灭菌资源方面的差异，而这些因素都会影响产品选择、包装以及对供应商的服务期望。

这些细分镜头共同提供了一个细緻的框架，用于将研发投资、临床检验计划和商业策略与特定的手术工作流程和购买行为相结合。

美洲、欧洲、中东和非洲以及亚太地区的临床实践、法规环境和供应链特征将如何决定差异化的上市方法

区域动态对眼科缝合线的法规结构、报销实务和供应链设计有重大影响。在美洲，既定的临床路径和高手术量对一致性、外科医生培训支援和经过验证的产品性能提出了强烈的需求，而检验团队则青睐能够展示强大品质系统和快速交货的供应商。在欧洲、中东和非洲地区，多样化的法规以及不同的公立和私立医疗保健组合需要灵活的打入市场策略、基于本地的临床证据以及能够应对不同报销系统和医院采购模式的有针对性的分销商合作伙伴关係。

在亚太地区，先进外科技术的快速普及与广泛的医疗保健基础设施并存，迫使供应商既要提供高性能产品线，又要提供具有成本竞争力的产品规格，以满足多样化的需求。供应链的考量因素，例如前置作业时间、本地製造地和临床教育要求，在不同地区存在显着差异，需要相关人员相应地调整其市场进入策略。从一个地区过渡到另一个地区，不仅需要调整监管文件和标籤，还需要调整培训、包装尺寸和服务模式，以适应当地医院的工作流程和外科医生的期望。

因此，有效的区域策略将平衡集中的产品卓越性与分散的执行，并考虑每个地区的临床和商业性现实。

决定眼科缝合线领域竞争优势的关键企业能力、经销伙伴和品质保证实践

眼科缝合线的竞争格局由那些将先进材料专业知识与强大的临床医生协作能力和可靠的供应链相结合的公司所塑造。领先的製造商投资于聚合物开发、线材表面工程和客观的可用性测试，以提升产品性能，例如打结安全性、组织抗性以及在显微镜下的操作性。同样重要的是，能够透过合作研究来支持​​临床检验，并提供培训以促进外科医生的采用，而外科医生通常依赖触觉回馈来选择产品。

分销合作伙伴和委託製造也透过提供规模、区域市场准入和无菌加工能力发挥战略作用。在医院和门诊中心评估供应商风险时，那些拥有透明品质系统、一致的批次间性能和强大的监管文件记录的公司将更具优势。此外，那些积极追求包装和製造流程永续性，且不损害无菌药品完整性的公司，越来越受到注重长期营运弹性的采购团队的青睐。

总而言之，该领域的成功需要一个平衡的投资组合，其中包括材料创新、以临床医生为中心的证据产生以及预测当地合规性和物流要求的敏捷供应模式。

为製造商和经销商提供切实可行的优先行动，使创新、检验和供应弹性与临床和采购优先事项保持一致

产业领导者应采取协调一致的策略，将产品创新、临床检验和供应链韧性结合起来，以满足不断变化的外科需求和采购预期。首先，优先考虑针对明确临床痛点的开发项目，例如降低组织阻力、提高超细规格的打结安全性以及实现批次间处理的一致性，并透过外科医生主导的可用性研究和记录在案的实验室性能评估检验这些进展。其次，实现采购多元化，建立替代供应商和近岸生产，以减轻关税和海关波动的影响，同时维持替代材料的等效性检验通讯协定。

第三，商业性，以满足门诊手术中心、眼科诊所和医院的不同需求，并投资于能够展示该技术独特优势的临床医生教育计画。第四，我们将透过加强品质体系的透明度、提供原产国文件以及纳入应对贸易政策波动的合约保护措施来提高采购的可靠性。最后，我们将尽可能融入永续性考虑，透过优化无菌包装和减少废弃物，同时不损害无菌性，满足日益增长的医疗服务提供者的期望，并支持与医疗服务提供者的长期伙伴关係。

这种协作行动将有助于製造商和经销商在保护临床可靠性的同时，在性能、服务和营运弹性的基础上创造差异化。

清楚解释主要和次要研究方法、数据三角测量和局限性，为眼科缝合线的策略分析提供信息

该研究结合了对外科医生、采购主管和行业专家的初步调查，以及对监管指南、材料科学文献和已发表的与眼科缝合线性能相关的临床研究的二次研究。一级资讯来源包括与各专科眼科医师、门诊手术中心和医院的采购负责人以及负责验证进货批次的灭菌和品质保证专业人员进行的结构化访谈和检验可用性会议。二级资讯来源包括关于聚合物生物相容性、线结动态和缝合线处理的同行评审研究，以及概述主要司法管辖区无菌医疗设备要求的监管文件。

该分析采用了临床医生报告的偏好与台架试验证据的交叉验证方法，以评估组织阻力、结节安全性和拉伸保持力等属性。供应链影响评估纳入了贸易政策变化、经销商网路结构和典型的前置作业时间情景，以评估潜在的采购回应。局限性包括在地采购实践的差异性和不断变化的贸易政策，这两项因素均通过基于情景的敏感性检查和专家支持意见进行了处理。在适当的情况下，建议会根据替代采购和监管情境进行压力测试，以确保其对决策者的实用性。

决策者应整合临床、商业和供应链必要条件，以确保一致的绩效和采购弹性

眼科缝合线处于材料科学、显微外科技术和医疗保健采购的关键交叉点，需要采取细緻入微的方法，将临床证据与供应可靠性相结合。最有效的策略是强调由外科医生主导的可用性测试和客观基准指标检验的可证明产品性能，以及在灭菌、记录和物流的卓越运作。区域和政策动态（包括最近的关税调整）凸显了多元化采购和合约保护的必要性，以确保医院、门诊手术中心和眼科诊所的供应连续性。

展望未来，相关人员，将最有能力满足眼科实践不断变化的需求。透过将这些要素整合到连贯的商业性和临床策略中，製造商和经销商能够提供既能满足外科医生触觉期望，又能满足机构买家操作需求的产品，最终有助于改善患者的治疗效果。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 越来越多采用抗菌涂层眼科缝合线来预防术后感染
  • 复杂眼科手术对可吸收合成缝线的需求不断增加
  • 用于术后标靶治疗和癒合支持的药物释放型眼科缝线的生长
  • 生物活性奈米纤维缝合涂层促进角膜组织再生的研究进展
  • 机器人辅助显微外科技术的扩展增加了对精准医疗的需求
  • 用于大容量白内障手术的新型可生物降解缝合聚合物已获得监管部门核准
  • 亚太新兴市场对经济高效的眼科缝合解决方案的采用正在增加
  • 开发嵌入感测器的智慧缝合线，用于眼科手术的即时伤口监测
  • 在眼科缝合线分销链中整合环保和永续包装
  • 无缝线组织黏合技术外科医生培训计画的快速增加影响了缝合量

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 眼科缝合线市场（依产品类型）

  • 吸收性
    • 氧环己酮聚合体
    • Polyglactin910
    • Polyglycolic
  • 不可吸收
    • 聚酰胺
    • 聚酯纤维
    • 丝绸

9. 眼科缝合线市场（依材料）

  • 聚酰胺
  • 氧环己酮聚合体
  • 聚酯纤维
  • Polyglactin910
  • Polyglycolic
  • 丝绸

第 10 章眼科缝合线市场（依缝合线类型）

  • 编织
  • 单丝

第11章眼科缝合线市场（依应用）

  • 白内障
  • 角膜
  • 青光眼
  • 镜头维修

第12章眼科缝合线市场（依最终用户）

  • 门诊手术中心
  • 眼科诊所
  • 医院

第 13 章。眼科缝合线市场（依缝合线尺寸）

  • 10-0
  • 6-0
  • 7-0
  • 8-0
  • 9-0

第十四章眼科缝合线市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章眼科缝合线市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 眼科缝合线市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Ethicon, Inc.
    • B. Braun Melsungen AG
    • Alcon Inc.
    • Teleflex Incorporated
    • Medtronic plc
    • Merit Medical Systems, Inc.
    • Peters Surgical Limited
    • Serag-Wiessner GmbH & Co. KG
    • SUTUREMED Co., Ltd.
    • Medical Micro Instruments, Inc.
Product Code: MRR-221461476CEA

The Ophthalmic Sutures Market is projected to grow by USD 780.93 million at a CAGR of 7.86% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 426.07 million
Estimated Year [2025] USD 459.02 million
Forecast Year [2032] USD 780.93 million
CAGR (%) 7.86%

Concise introduction to the clinical priorities, technical differentiators, and purchasing drivers shaping modern ophthalmic suture selection across surgical settings

Ophthalmic sutures remain a foundational component of anterior and posterior segment surgery, with nuanced differences in material science, handling characteristics, and regulatory pathways driving clinical choice. Over the past decade, surgeons and procurement teams have increasingly prioritized outcomes such as reduced tissue reaction, predictable knot security, and ease of handling under microscopic visualization. These priorities have fueled diversification in both absorbable and nonabsorbable options and prompted suppliers to refine polymer formulation and filament architecture to meet microsurgical demands.

Clinical practice has migrated toward specialized suture sizes and formats to support delicate ocular tissues; ultrafine gauges from 10-0 through 9-0 accommodate precise corneal and lens repair while slightly larger sizes serve broader reconstructive needs. At the same time, suture type distinctions-braided versus monofilament-affect tissue drag, knot profile, and infection risk, influencing surgeon selection depending on the procedure. In parallel, end user environments including ambulatory surgery centers, dedicated eye clinics, and hospital ophthalmology departments are shaping purchasing criteria through case mix, throughput needs, and sterile processing capabilities.

Taken together, these dynamics set the stage for strategic investment in product training, supply reliability, and targeted material innovation that aligns with surgeon technique and institutional requirements.

How polymer innovation, microsurgical technique evolution, and procurement consolidation are fundamentally reshaping clinical use and supplier strategies for ophthalmic sutures

Recent years have delivered several transformative shifts that recalibrate how manufacturers, clinicians, and supply chain stakeholders approach ophthalmic sutures. Advances in polymer chemistry and filament engineering have refined absorbable offerings such as polydioxanone and polyglactin 910 while also improving the surface finish and tensile reliability of nonabsorbable fibers like polyamide and polyester. These material-level innovations have reduced tissue drag and enhanced knot security, translating directly into intraoperative efficiency and postoperative healing trajectories.

Concurrently, clinical technique evolution and heightened emphasis on minimally invasive approaches have amplified demand for ultrafine suture sizes and monofilament options that permit atraumatic passage through delicate ocular tissue. Training and surgeon preference trends underscore the importance of handling characteristics; as a result, manufacturers are investing in tactile testing and surgeon-led usability studies to differentiate product lines. Another notable shift is the consolidation of procurement pathways and a push for just-in-time stocking in ambulatory surgery centers, eye clinics, and hospital departments, which elevates the importance of consistent supply and validated sterilization practices.

Together, these shifts require stakeholders to balance innovation with rigorous clinical validation and reliable logistics, creating opportunities for companies that can demonstrate both material performance and supply resilience.

Assessing the implications of United States tariff adjustments in 2025 on sourcing strategies, supply chain resilience, and contractual terms for ophthalmic suture supply

Policy shifts and tariff adjustments in the United States in 2025 have introduced new variables into procurement and sourcing strategies for surgical consumables, including ophthalmic sutures. Heightened import levies on certain medical device categories have prompted healthcare buyers and distributors to re-evaluate supplier footprints and to explore nearshoring or regional sourcing models that can mitigate customs exposure and lead-time risk. In response, some manufacturers have accelerated local manufacturing investments or established dual-sourcing agreements to preserve continuity for hospitals, ambulatory surgery centers, and eye clinics.

These changes have also influenced commercial contracting mechanics. Buyers increasingly seek longer-term agreements with price-variance clauses tied to trade policy changes and insist on greater transparency around country-of-origin labeling and tariff pass-through. For product development teams, regulatory and customs complexity has reinforced the value of harmonized quality systems and well-documented compliance evidence that supports alternate sourcing where necessary. From a clinical perspective, practitioners remain focused on consistency of product performance; therefore, any changes in supply chain or material sourcing must be validated through bench testing and clinical equivalency protocols prior to large-scale adoption.

Overall, the 2025 tariff environment has accelerated supply chain diversification, emphasized the importance of sourcing transparency, and reshaped negotiations between suppliers and end users to ensure uninterrupted delivery of clinically critical ophthalmic suture products.

Detailed segmentation-driven insights connecting polymer chemistry, filament architecture, surgical application, and end user procurement behaviors to product strategy

Understanding product and application segmentation illuminates where clinical needs and supplier capabilities intersect most meaningfully. When products are categorized by Product Type into absorbable and nonabsorbable classes, absorbable options such as polydioxanone, polyglactin 910, and polyglycolic acid are often preferred when tissue absorption and reduced long-term foreign body presence are clinical priorities, whereas nonabsorbable fibers such as polyamide, polyester, and silk remain relevant for indications requiring durable tensile support. Looking at Material, discrete polymer choices including polyamide, polydioxanone, polyester, polyglactin 910, polyglycolic acid, and silk infer distinct handling profiles and biocompatibility considerations that guide surgeon selection and labeling requirements.

Suture Type segmentation into braided versus monofilament formats highlights trade-offs between knot security and tissue drag, which are particularly relevant for ultrafine suture sizes like 10-0, 9-0, 8-0, 7-0, and 6-0 used in anterior segment procedures. Application segmentation covering cataract, cornea, glaucoma, and lens repair clarifies clinical procedural demands and informs portfolio prioritization; for example, cataract and corneal surgeries often require the finest diameters and lowest tissue drag, while glaucoma procedures may emphasize longer-term tensile stability. End User segmentation across ambulatory surgery centers, eye clinics, and hospitals underscores differences in procurement cycles, inventory volume, and sterilization resources, each of which shapes product selection, packaging format, and service expectations from suppliers.

Integrating these segmentation lenses provides a granular framework for aligning R&D investments, clinical validation programs, and commercial strategies to specific surgical workflows and purchasing behaviors.

How regional clinical practices, regulatory environments, and supply chain characteristics across the Americas, Europe Middle East & Africa, and Asia-Pacific dictate differentiated go-to-market approaches

Regional dynamics exert substantial influence on regulatory frameworks, reimbursement practices, and supply chain design for ophthalmic sutures. In the Americas, well-established clinical pathways and high procedural volumes drive strong demand for consistency, surgeon training support, and validated product performance, while procurement teams favor suppliers that can demonstrate robust quality systems and rapid fulfillment. Across Europe, Middle East & Africa, regulatory heterogeneity and differing public versus private healthcare mixes create a need for flexible market entry strategies, localized clinical evidence, and targeted distributor partnerships that can navigate varied reimbursement and hospital purchasing models.

In the Asia-Pacific region, rapid adoption of advanced surgical techniques coexists with a wide spectrum of healthcare infrastructure, prompting suppliers to offer both premium performance lines and cost-competitive formats to meet diverse needs. Supply chain considerations such as lead time, local manufacturing presence, and responsiveness to clinical education requests vary significantly across these geographies, and stakeholders should tailor their market access approach accordingly. Transitioning from one region to another requires adaptation not only in regulatory dossiers and labeling but also in training, packaging sizes, and service models to align with local institutional workflows and surgeon expectations.

Consequently, effective regional strategies balance centralized product excellence with decentralized execution that acknowledges the clinical and commercial realities of each territory.

Key corporate competencies, distribution partnerships, and quality assurance practices that define competitive advantage in the ophthalmic suture sector

The competitive landscape for ophthalmic sutures is shaped by companies that combine advanced materials expertise with strong clinician engagement and supply chain reliability. Leading manufacturers invest in polymer development, filament surface engineering, and unbiased usability testing to refine product attributes such as knot security, tissue drag, and handling under microscopy. Equally important is the capability to support clinical validation through collaborative studies and to provide training that accelerates adoption among surgeons who often rely on tactile feedback for product selection.

Distribution partners and contract manufacturers also play a strategic role by offering scale, local market access, and sterile processing competencies. Companies that demonstrate transparent quality systems, consistent lot-to-lot performance, and robust regulatory documentation gain an advantage when hospitals and ambulatory centers evaluate supplier risk. Moreover, organizations that proactively address sustainability in packaging and manufacturing processes, while not compromising sterile integrity, are increasingly preferred by procurement teams focused on long-term operational resilience.

In sum, success in this space requires a balanced portfolio of material innovation, clinician-centered evidence generation, and an agile supply model that anticipates regional compliance and logistical requirements.

Practical and prioritized actions for manufacturers and distributors to align innovation, validation, and supply resilience with clinical and procurement priorities

Industry leaders should adopt a coordinated strategy that aligns product innovation, clinical validation, and supply chain resilience to capitalize on evolving surgical needs and procurement expectations. First, prioritize development programs that target clear clinical pain points-such as reducing tissue drag, improving knot security in ultrafine gauges, and delivering consistent handling across lots-and validate these advances through surgeon-led usability studies and documented bench performance assessments. Second, diversify sourcing footprints and establish alternate suppliers or nearshore manufacturing to mitigate tariff exposure and customs volatility while maintaining equivalency validation protocols for any material substitutions.

Third, tailor commercial engagement by offering flexible packaging and stocking options that suit the distinct needs of ambulatory surgery centers, eye clinics, and hospitals, and invest in clinician education programs that demonstrate technique-specific benefits. Fourth, enhance procurement confidence by strengthening quality system transparency, providing country-of-origin documentation, and including contractual protections that address trade policy fluctuations. Finally, integrate sustainability considerations where feasible-optimizing sterile packaging and waste reduction without compromising sterility-to meet growing institutional expectations and support long-term institutional partnerships.

These coordinated actions will help manufacturers and distributors safeguard clinical reliability while creating differentiation grounded in performance, service, and operational resilience.

Transparent description of primary and secondary research methods, data triangulation, and limitations informing the ophthalmic suture strategic analysis

This research synthesizes primary interviews with surgical practitioners, procurement leaders, and industry experts combined with secondary review of regulatory guidance, materials science literature, and publicly available clinical studies relevant to ophthalmic suture performance. Primary inputs included structured interviews and qualitative usability sessions with ophthalmic surgeons across subspecialties, procurement officers from ambulatory surgery centers and hospitals, and sterilization and quality assurance professionals who validate incoming product lots. Secondary sources encompassed peer-reviewed studies addressing polymer biocompatibility, knot mechanics, and suture handling, as well as regulatory documents outlining sterile medical device requirements across major jurisdictions.

The analysis applied cross-validation between clinician-reported preferences and bench testing evidence for attributes such as tissue drag, knot security, and tensile retention. Supply chain impact assessments incorporated trade policy changes, distributor network structures, and typical lead-time scenarios to evaluate potential procurement responses. Limitations include variability in local procurement practices and the evolving nature of trade policy, both of which were addressed through scenario-based sensitivity checks and corroborative expert input. Where appropriate, recommendations were stress-tested against alternate sourcing and regulatory scenarios to ensure practical applicability for decision-makers.

Concluding synthesis of clinical, commercial, and supply chain imperatives that decision-makers should integrate to secure consistent performance and procurement resilience

Ophthalmic sutures occupy a critical intersection of materials science, microsurgical technique, and healthcare procurement, requiring a nuanced approach that bridges clinical evidence with supply reliability. The most effective strategies emphasize demonstrable product performance-validated through surgeon-driven usability testing and objective bench metrics-alongside operational excellence in sterilization, documentation, and logistics. Regional and policy dynamics, including recent tariff adjustments, underscore the need for diversified sourcing and contractual protections to ensure continuity of supply for hospitals, ambulatory surgery centers, and eye clinics.

Looking forward, stakeholders that prioritize targeted polymer improvements, invest in training that aligns product characteristics with surgical technique, and maintain transparent quality documentation will be best positioned to meet the evolving demands of ophthalmic practice. By integrating these elements into coherent commercial and clinical strategies, manufacturers and distributors can deliver products that satisfy both the tactile expectations of surgeons and the operational requirements of institutional purchasers, ultimately supporting improved patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of antimicrobial-coated ophthalmic sutures to prevent post-surgical infections
  • 5.2. Increasing demand for absorbable synthetic suture materials in complex ocular procedures
  • 5.3. Growth of drug-eluting ophthalmic sutures for targeted postoperative therapy and healing support
  • 5.4. Advancements in bioactive nanofiber suture coatings to enhance corneal tissue regeneration
  • 5.5. Expansion of robotic-assisted microsurgical techniques driving demand for precision ophthalmic sutures
  • 5.6. Regulatory approvals for novel biodegradable suture polymers in high-volume cataract surgeries
  • 5.7. Asia-Pacific emerging markets fueling increased adoption of cost-effective ophthalmic suture solutions
  • 5.8. Development of smart sutures with integrated sensors for real-time wound monitoring in eye surgeries
  • 5.9. Integration of eco-friendly and sustainable packaging in ophthalmic suture distribution chains
  • 5.10. Surge in surgeon training programs for sutureless tissue adhesive techniques impacting suture volumes

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ophthalmic Sutures Market, by Product Type

  • 8.1. Absorbable
    • 8.1.1. Polydioxanone
    • 8.1.2. Polyglactin 910
    • 8.1.3. Polyglycolic Acid
  • 8.2. Non Absorbable
    • 8.2.1. Polyamide
    • 8.2.2. Polyester
    • 8.2.3. Silk

9. Ophthalmic Sutures Market, by Material

  • 9.1. Polyamide
  • 9.2. Polydioxanone
  • 9.3. Polyester
  • 9.4. Polyglactin 910
  • 9.5. Polyglycolic Acid
  • 9.6. Silk

10. Ophthalmic Sutures Market, by Suture Type

  • 10.1. Braided
  • 10.2. Monofilament

11. Ophthalmic Sutures Market, by Application

  • 11.1. Cataract
  • 11.2. Cornea
  • 11.3. Glaucoma
  • 11.4. Lens Repair

12. Ophthalmic Sutures Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Eye Clinics
  • 12.3. Hospitals

13. Ophthalmic Sutures Market, by Suture Size

  • 13.1. 10-0
  • 13.2. 6-0
  • 13.3. 7-0
  • 13.4. 8-0
  • 13.5. 9-0

14. Ophthalmic Sutures Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Ophthalmic Sutures Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Ophthalmic Sutures Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Ethicon, Inc.
    • 17.3.2. B. Braun Melsungen AG
    • 17.3.3. Alcon Inc.
    • 17.3.4. Teleflex Incorporated
    • 17.3.5. Medtronic plc
    • 17.3.6. Merit Medical Systems, Inc.
    • 17.3.7. Peters Surgical Limited
    • 17.3.8. Serag-Wiessner GmbH & Co. KG
    • 17.3.9. SUTUREMED Co., Ltd.
    • 17.3.10. Medical Micro Instruments, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. OPHTHALMIC SUTURES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. OPHTHALMIC SUTURES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. OPHTHALMIC SUTURES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY BRAIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY BRAIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY BRAIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY BRAIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY BRAIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY BRAIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY MONOFILAMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY MONOFILAMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY MONOFILAMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY MONOFILAMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY MONOFILAMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY MONOFILAMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CATARACT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CATARACT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CATARACT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CATARACT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CATARACT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CATARACT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CORNEA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CORNEA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CORNEA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CORNEA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CORNEA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CORNEA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY GLAUCOMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY GLAUCOMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY GLAUCOMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY GLAUCOMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY GLAUCOMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY LENS REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY LENS REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY LENS REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY LENS REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY LENS REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY LENS REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY EYE CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY EYE CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY EYE CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY EYE CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY EYE CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY EYE CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 10-0, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 10-0, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 10-0, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 10-0, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 10-0, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 10-0, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 6-0, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 6-0, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 6-0, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 6-0, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 6-0, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 6-0, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 7-0, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 7-0, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 7-0, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 7-0, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 7-0, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 7-0, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 8-0, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 8-0, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 8-0, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 8-0, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 8-0, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 8-0, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 9-0, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 9-0, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 9-0, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 9-0, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 9-0, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY 9-0, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 304. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 305. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 306. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 307. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 308. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 309. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 312. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 313. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 315. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2018-2024 (USD MILLION)
  • TABLE 316. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2025-2032 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 322. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 323. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 324. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 325. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 326. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 327. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 330. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 331. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2018-2024 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE SIZE, 2025-2032 (USD MILLION)
  • TABLE 335. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 336. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 337. ASEAN OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 338. ASEAN OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 339. ASEAN OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. ASEAN OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILL